9/09/2011

Dr Kim Chan awarded the top rated abstract for the AHA conference

Dr Kim Chan from the Translational Research Group has been awarded the top rating abstract for the American Heart Association (AHA) Annual Scientific Sessions.

The Scientific Session is the AHA’s largest gathering of scientists and health care professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases.

Kim’s has been studying an enzyme called heme-oxygenase-1, previously known for its role in breaking down the hemeoglobin component of red blood cells. But Kim’s research has revealed HO-1 may also be involved in the repair of blood vessels during cardiovascular disease.

During heart attack or stoke, blood vessels are deprived of oxygen, and when the constriction is released molecules come rushing in to assist in repair. In systems where there was no HO-1, Kim found that repair did not take place. But when the vessels had access to HO-1 new vessels grew to replace the damaged ones. These findings have implications for therapy following heart attack, a time when the vessels are particularly sensitive to damage and even death.

Kim is currently in his second year of a PhD as a cardiology research fellow. Since beginning his training in cardiology in 2007, Kim has won several awards including the Royal Prince Alfred (RPA) Cardiologist’s Award for the Best Publication by a Clinical Scientist. His work on HO-1 also attracted the prestigious RPA Patron’s Prize in August.

Kim will present his breakthough work at the AHA Sessions in Orlando, Florida from November 12-16. The conference showcases over 4000 presentations given by some of the world’s leaders in the area of cardiovascular disease.